Nothing
################################################################################
##
## clusrank: Wilcoxon Rank Tests for Clustered Data
## Copyright (C) 2015-2022 Yujing Jiang, Mei-Ling Ting Lee, and Jun Yan
##
## This file is part of the R package clusrank.
##
## The R package clusrank is free software: You can redistribute it and/or
## modify it under the terms of the GNU General Public License as published by
## the Free Software Foundation, either version 3 of the License, or any later
## version (at your option). See the GNU General Public License at
## <https://www.gnu.org/licenses/> for details.
##
## The R package clusrank is distributed in the hope that it will be useful,
## but WITHOUT ANY WARRANTY without even the implied warranty of
## MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE.
##
################################################################################
#' CARMS scores
#'
#'A data set from a research on complement factor H R1210C rare variant
#'and its associated phenotype.
#'This data set contains Clinical
#'Age-Related Maculopathy Staging (CARMS) scores
#'from a total of 143 patients (283 eyes), including
#'62 patients with the rare variant,
#'The data is from the lab of Dr. Johanna M. Seddon,
#'
#'
#'
#'
#' @format A data frame with 283 rows and 7 variables.
#'
#' \itemize{
#' \item ID patient identifier
#' \item Eye OD (right eye), OS(left eye)
#' \item Variant 1: No R1210C Variant; 2: R1210C Variant
#' \item CARMS Patient's last CARMS grade, related to age-related
#' macular degeneration (AMD). 1: no AMD; 2: early AMD; 3:
#' intermediate AMD; 4: geographic atroph(advanced dry); 5:
#' neovascular disease (advanced wet)
#' \item Age_group 1: < 70 years; 2: 70 to 79.9 years; 3: >= 80 years
#' \item Sex 1: male; 2: female
#' \item AgeSex 1: agegroup = 1, sex = 1; 2: agegroup = 2, sex = 1;
#' 3: agegroup = 3, sex = 1; 4: agegroup = 1, sex = 2; 5: agegroup
#' = 2, sex = 2; 6: agegroup = 3, sex = 2;
#' }
#'
#' @name amd
#' @docType data
#' @note CARMS grades were assessed separately for
#' the two advanced stages (4 and 5):
#' 1. CARMS 1,2,3, and 4 was assessed;
#' 2. CARMS 1,2,3, and 5 was assessed
#' @source The data came from Seddon's lab.
#' @references Seddon JM, Sharma S, Adelman RA (2006)
#' \emph{Evaluation of the Clinical Age-related
#' Maculopathy Staging System.}
#' Ophthalmology, \bold{113}, 260-266.
#' @references Ferrara D, Seddon JM (2015)
#' \emph{ Phenotypic characterization of complement
#' factor H R1210C rare genetic variant in
#' age-related macular degeneration}
#' JAMA Ophthalmol, 2015 Apr 16.
#' doi:10.1001/jamaophthalmol.2015.0814.
#' @examples
#' data(amd)
#' clusWilcox.test(CARMS ~ Variant + cluster(ID), data = amd,
#' subset = CARMS %in% c(1, 2, 3, 4), method = "rgl", alternative = "two")
#' clusWilcox.test(CARMS ~ Variant + cluster(ID), data = amd,
#' subset = CARMS %in% c(1, 2, 3, 4), method = "ds", alternative = "two")
#' clusWilcox.test(CARMS ~ Variant + cluster(ID) + stratum(AgeSex), data = amd,
#' subset = CARMS %in% c(1, 2, 3, 4), alternative = "two")
#' @keywords datasets
NULL
Any scripts or data that you put into this service are public.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.